PAFSC’s First Committee Recommends Approval for Takeda’s Lotriga

August 7, 2012
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs on August 3 recommended approval for four products/indications including Takeda Pharmaceutical’s hyperlipidemia treatment Lotriga Granular Capsules 2 g (omega-3-acid ethyl esters). Formal approval is expected in about a...read more